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Summary
In a selected group ofrhinitis palients with an IgE-mediated allergy to house dust mites
the nasal response to insufflation of histamine chloride, methacholine and phentola-
mine was demonstrated to he higher than in a control group. With the methods used
histamine chloride was better at discriminating between healthy subjects and patients
than methacholine or phentolamine. This discrimination was shown by assessing the
severity of reflex-mediated symptoms such as the number of sneezes and the amount of
secretion, and not by differences in nasal airway resistance.
Introduction
Non-specific hyperreactivity is a well-known phenomenon in bronchial asthma,
Hyperreactivity is characterized by quantitative changes in the response of lung
function to bronchial provocation with substances such as histamine or methacholine
[1-3]. Although non-speciftc stimuli such as damp or changes of temperature can also
induce nasal symptoms in rhinitis, there are no reliable tests to measure nasal
hyperreactivity in an objective way [4]. Non-specific reactivity of the nose can be
measured by means of nasal provocation tesls with agents such as histamine and
methacholine [4]. There is, however, no standard way of assessing the nasal response
after provocation. In histamine provocation the increase in nasal airway resistance
(NAR) is often used as a parameter of nasal response [5-7] but thenumber of sneezes
[8] or even a "tickling score* [9] has been used for this purpose.
Several explanations for nasal hyperreactivity are possible., such as increased
mucosal permeability, changes in irritant receptors or reflex activity and changes in
vessels and glands of the nasal mucosii [10], The tendency for rhinitis patients to suffer
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from nasal stuffiness could perhaps also be explained by a nasal a-adrenergic
dysfunction.
The aim of this study was two-fold. Originally, we tried lo establish the best agent
for discriminating between ailergic rhinitis patients and healthy controls, using three
provocative test agents: histamine. methacholine and phentolamine. The agents were
chosen because oftheir different method ofaction on nasal mucosa. Histamine has an
effect on both irritant receptors, thus stimulating nerves, and on vessels, thus causing
nasal congestion [10]. Conversely, methacholine has a direct stimulating effect on
glands [10] and phentolamine causes vasodilatation [II]. Secondly, we chose
phentolamine. an alpha-receptor blocking agent, to investigate the a-adrenergic
responsiveness ofthe nasal mucosa.
Subjects and methuds
Study design
Normal subjects and selected patients with a house dusl mite (HDM) allergy
underwent nasal provocation tests with histamine. methacholine and phentolamine (in
this sequence) on scparale days. The investigation period was restricted to 1 week for
each patient. The group of healthy individuals v\as investigated during summer 1984
and the patients in September-November, this being the period with the highest
number of housedust mites in Holland [12].
Subjects
Thirteen patients (six females, seven males), with perennial rhinitis that had lasted for
more than 1 year, took part in the study. Their ages ranged from 19 to .''I with a median
of 25 years.
Selection was based upon diagnosis of HDM allergy, confirmed by intradermal
skin tests and radio-allergo-sorbent tesls (RAST). With skin-test titralion. positive
reactions were found at low concentrations (I Noon unit/ml). Specific IgE to HDM
extract was high (class 3 or 4). None had previously received immunotherapy. Five
palients had u pollen aiiergy and live also had un allergy to pets {without having pets in
the house). Eighteen healthy students {nine females, nine males), without clinical signs
and symptoms of rhinitis or aslhma. participated in the study. Their ages ranged from
21 to 35 with a median of 25 years. None of the subjects had positive skin tests for a
routine series ofinhalanl allergen extracts, neither had they specific IgE to HDM. grass
pollen or cat dander, as measured with the RAST.
The study was approved by the Ethical Committee ofthe University Hospital and
Medical Eaculty, Erasmus University, Rotterdam. Alt participants gave their
informed consent before taking part in the study.
Agents
Histamine chloride was used in the following concentrations: 0 25. 0 5. I. 2. and 4 mg/
ml; methacholine in the concentrations S, 16, 32. and 64 mg ml; phentolamine in the
concentrations 1, 2,4, and 8 mg/ml. The concentrations of phentolamine were chosen
after consulting a cardiologist and taking into account the fad ihat na.sal absorption of
the drug is virtually complete.
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Na.sal provocation tests
In thccaseofthepatients, medication was withheld 2 days before the test. None ofthe
subjects used topical corticosteroids or long-lasting aniihisiamines. Airway infections
during ihe 2 weeks preceding the tests had been excluded.
On each occasion subjects waited half an hour before the test lo allow the nasal
mucosa to become acclimatized. After rhinoscopy a control solution (phosphate
buffered saline containing human serum albumin OO3'!^ » and benzalkonium chloride
005"'..) was sprayed into the nostrils with a nasal pump spray delivering a fixed dose of
013 ml solution. After provocation wilh the conlrol solution, increasing doses of
histamine chloride or methachotine or phentolamine were applied in both nostrils. The
interval belween each dose was 5 min in ihc case of histamine and 15 min in the case of
methacholine and phentolamine.
After each provocalion wilh histamine the subject was asked to bend forwards and
to collect secretion in a syringe-equipped funnel, using the method introduced by
Borum [13]. Sneezes were counted and just before ihc next provocation the NAR was
measured three times. The median value was taken as the nasal airway resistance.
When melhacholine was used, secretion only was collected as methacholine has no
effect on nasal resistance [13]. In the case of phentolamine the NAR was monitored.
The nasal resistance of each nostril was measured using a passive anterior rhinoman-
ometer (Heyer PAR) as previously described [14]. This entailed blowing an air stream
wilh a fixed flow of 0 25 I/sec into each noslril. The resistance for the left (^ i^) and the
right (Rr) cavity were calculated by dividing the nasal pressure by the flow. The total
nasal resistance was computed from the formula:
Statistical analysis
Eor paired observations the Wilcoxon signed rank test was used. For comparison of
the palients and controls the Wilcoxon rimk-sum test was used. A P value of 0 05 or
less was considered as statistically significant.
il
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Fijj. 1. Relationship between the concentration of bo\h histamine (open symbols) and phentolamine (closed
symbols) and the median nasiil airway resistance Un patients (O. • ) and controls (D. • ] , The asterisk
represents a signiJicatit higher responst' in patients than in controls (*: /*<005).
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Results
Seventeen healthy subjects participated in ihe histamine provocation tests and eighteen
in the methacholine and phentolamine lesls. In the group of rhinitis palients thirteen
hislamine. iwelve melhacholinc and eleven phentolamine provocation tests were done.
One patient was withdrawn from the phentolamine provocation test because of
dizziness. The three agents had dilferenl effects on the nose. Both histamine and
phentolamine induced an inereasein nasal resistance in the control and patient groups
but only in thecaseof phentolamine was the nasal response higher in the paiient jiroup
than in the control group (Eig. I). No significant differences could be found in baseline
NAR belween patients and controls in either histamine or phentolamine provocation
tests (Table I). Both histamine and methacholine induced a higher secretory response
in the patient group than in the control group (Eig. 2). In contrast, phentolamine had
no effect on the nasal secretion. Histamine was capable ofeliciting a sneeze reflex in the
patient group (Eig. 3) whereas melhacholine induced sneezes in only four patients and
phentolamine caused no sneezes at all.
Significant side-eflects ofthe nasal provocation tests were not seen. In the case of
phentolamine one patient complained of dizziness during phentolamine provocalion,
however there was no objective change in pulse rate and blood pressure. Phentolamine
used al a concentration of 8 mg/ml caused a transient painful burning sensation In the
nose and so higher concentrations could not he used.
All median values plotted in Eigs 1-3 represent a large range of individual values.
In order to discriminate between patients and controls in a way that is easy to use in
Table I. Initial baseline values of NAR* before provoca*
lion with histamine or phentolamine
Histamine Phentolamine
Controls Patients Controls Patients
Median
Range
Sign ilica nee
18
12 25
n,s
19
11 51
20
11 ?
28
16 14-52
n,s.
" Expressed in mm HjO/Iit re/sec.
clinical practice, we used an end-point titration method. Table 2 shows the histamine
end-point concentrations using three different definitions of end-point. The metlian
end-point concentrations required to double nasal resistance do not diflcr between ihe
conlrol and patient groups. In contrast, median end-point concentration needed to
give 0 5 ml secretion and/or five sneezes is eight times lower in the patient group than in
the control group (0 50 vs 4 mg/trtl). A combination of symploms does not enable a
better distinction lo be made between patients and controls.
A preliminary study of the variability of nasal provocation tests with histamine
showed that the reproducibility oi' the test was better using the end-point concenlra-
tions required to produce 0 5 ml secretion and/or live sneezes (to be published).
In the case of methacholine provocation the concentration needed to produce 0 5
ml secretion was at least 5 6 times lower in the patient group than in the conlrol group
(22 6 vs 128 mg/ml or more, P < 0 0 2 ; Wilcoxon rank-sum test).
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Control 0-25 0-50 1-0 2-0 4-0 histamine (mg/ml)
(PBSl
8 16 32 54 methocholme (mg/ml)
Fig. 2. Relationship between the conceniralion of both histamine (open symbols) and melhacholine (closed
symbols) and Ihe median amount ofsecret inn for patienls (O.») and controls (D.B), The asterisk represents
a signilicanl higher icsponse in patienls than in conlrols (*: P < 0 OS: **: P < 0 01).
10 h
Control 0-25 0-50 1-0 2-0 4-0 hislamrne (mg/ml)
(PBS)
Fig. 3. Relationship between the concentration of hisiamine and the median number of sneezes. (D)
Controls. (O) patients.
For phentolamine the concentration needed to double nasal resistance in the
patieni group (4 r.v 8 mg, ml, / ' < 0 05; Wilcoxon rank sum test) vvas half that required
for the controls.
Discussion
There are several studies of nasal response to non-specific stimuli [5-9, 13-20] but
attempts to discriminate between patients and healthy subjects have lead to conflicting
results [6 8. 13. 15 IH. 20]. The studies concerning nasal hyperreactivity differ from
each other in the provocation technique, the way of assessing the symptoms and in
selection of the patient population, which makes comparison of studies almost
impossible. With our methods we observed a hypcrresponsiveness to histamine.
methacholine and phentolamine in allergic rhinitis patients. There are several
possibilities ihat can explain the results. Firstly, increased permeability of the diseased
mucosa may enable a better penetration of ihe test agents. Conversely, the observation
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Table 2. End-point concentration of hist;imin(.- (mg ml) in patients and controls
Histamine end-point concentration
Inducing 100%
increase in
nasal resistance
Inducing al least (1-5 ml
secretion and or
at least live sneezes
Induring IOO'^ > increase in NAR.
and or (1-5 ml secretion and/or
live sneezes
025
2
:
I
3
3
4
050
1
1
T
4
3
4
10
7
4
2
.1
5
4
20
I
5
0
2
1
4 0
0
0
4
0
2
0
> 4 0
6
1
6
2
0
Controls (/! = 17)
Patients (M=f 3)
Controls
P < 0 05
Patients
Controls
P>0-Q5
Patients
that histamine has the same effect on the tiasal resistance of patients and controls,
suggests thiU a ditference in permeability might be of minor importance. The fact that
histamine leads to exaggerated secretory response and snee/e-retlex favours the second
hypothesis, which is that the reflc.\-mcdiated activity in allergic patients is elevated.
A third possibility is thai changes in glands and vessels are responsible fot the
observed hyperre;icli\ ity. The tendency to hypcrresponsiveness to phentolamine could
possibly reflect a defect in the a-adrenergic system. Comparable assumptions have
been made in bronchial asthma when using propanolol hyperresponsiveness is a
measure ofa defect in the /f-adrenergic system. Our observation would correspond
wilh the receptor-binding study of Ishibe ct al. [21]. who showed that there wjs a
decrease in the number ofalpha-1-adrenergie receptors in the nasal mucosa of patients
with nasal allergy. However, we cannot exclude the possibility ihat ihe response to
phentolamine may merely reflect a tion-specific hyperreactivity. Another problem is
ihat there was a slight, non-significant, dificrcncc in tnedian baseline nasal resistance
between patients and controls before provociuion with phenlolamine. This ccaild
theoretically inflticncc the outcome of ihe tcsis.
The finding ihat hisiamine has an equal effect on nasal resistance in patients and
controls conflicts with other studies [7. H]. However, in our protocol the NAR was
measured after a someiimes considerable amount of secretion had been collected m a
syringe-equipped funnel. It could be ihal differences in nasal resistance measured after
histamine provocalion in olher studies arc due lo a difference in the production of
secretion. Another possible explanation is that measurLMiicnl of total nasal resistance is
less reliable in deicciing differences than measurement ofone-sidcd nasal resistance. In
a recent study Corrado ct al. [2(l| showed ihai only u few rhinitis patients allergic lo
Dermatophagoides ptcronys.sinus respond to histamine provocation with rhinorrhoea.
In our study, however, patients were tested in autumn, as this is the season with the
highest exposure lo house dust mites. Recently we showed that nasal sensitivity to
house dusl mile and probably lo histamine is increased in this season [22], perhaps due
to a priming effecl. The ittcreased rellcx mediated response found in our study could
reflect the active state of the disease.
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To our knowledge no prospective studies of nasai hypcrrcacliviiy li;t\c been carried
out in large unselecled patieni groups. Uniil this is done the importance of nasal
provocation tests in daily clinical practice remains uncertain.
However, by using un end-point tiiration tiiethod this sttidy provides a simple way
of tneasuring nasal responsiveness and suggests that histumine is the best agent to use
in nasal provocation tests to discriminate belween normal subjects and allergic rhinitis
patients with active disease, provided ibat the assessment of nasal response is focused
on the rcllcx action of histamine (i.e. sneezes and secretion). The role of rhinomano-
metry in this test may be questioned. The results obtained with phenlolamine
provocation may reflect an x-adrenergic dysfunction ofthe nasal mucosa.
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